Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 861177 NEW YORK, NY

Position in DNA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$395,857
-$83,928 QoQ
Shares Held
64,577
+11.8% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 33.137185065890336.ToString("F0")% Shared 0.ToString("F0")% None 66.86281493410966.ToString("F0")%

Common Shares in DNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. DNA ranks #140 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNA

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $395,857 64,577
2025-12-31 $479,785 57,736
2025-09-30 $840,916 57,676
2025-06-30 $922,488 81,999
2025-03-31 $252,304 44,264
2024-12-31 $412,390 41,995
2024-09-30 $295,428 36,249